Amyl Nitrite
FDA Approves First Drug-Eluting Stent to Treat Peripheral Arterial Disease »
"The U.S. Food and Drug Administration approved the Zilver PTX Drug-Eluting Peripheral Stent (Zilver PTX Stent), the first drug-eluting stent indicated to re-open a particular artery in the thigh (femoropopliteal artery) when narrowed or blocked a"...
Read the FDA Approves First Drug-Eluting Stent to Treat Peripheral Arterial Disease article »
Amyl Nitrite
INDICATIONS
Amyl nitrite (amyl nitrite inhalant) is indicated for the rapid relief of angina pectoris. Its effect appears within 30 seconds and lasts for approximately 3 to 5 minutes.
DOSAGE AND ADMINISTRATION
With the patient in recumbent or seated position a capsule of amyl nitrite (amyl nitrite inhalant) is held away from the face, crushed between the fingers, and held under the patient's nose. Two to six inhalations of the vapors from the capsule are usually sufficient to promptly produce therapeutic effects. Caution is recommended to avoid inhalation of excessive amounts of the drug when it is administered by someone other than the patient. If necessary, the dose may be repeated in 3 to 5 minutes.
HOW SUPPLIED
JAMES ALEXANDER brand amyl nitrite (amyl nitrite inhalant) is furnished in covered glass capsules. Each capsule contains 0.3 ml in boxes of 12.
The capsule contents are FLAMMABLE and should be protected from light. Storage should be in a cold place, 2°-8°C (26°-46° F).
The James Alexander Corporation, Blairstown, New Jersey 07825. Rev. 02 December 2004. FDA revision date: 12/1/2004
Last reviewed on RxList: 9/25/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Amyl Nitrite Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Heart Health
Get the latest treatment options.
Updated & New
